Approval of the first drug to treat New World screwworm in U.S. livestock

The treatment, known as Dectomax-CA1 injectable solution, can also be used to prevent re-infestation for 21 days. “We understand the urgency with which American farmers and ranchers are requesting tools to combat the New World screwworm,” stated FDA Commissioner Marty Makary. “Today’s conditional approval, the first in the U.S. for the New World screwworm, demonstrates our dedication to advancing important veterinary medicines quickly when they are needed most. We continue to work tirelessly to complete the review of other New World screwworm products and to protect multiple animal species in the U.S.” Sponsored by the animal health company Zoetis, the Dectomax-CA1 injectable solution is available in 250 ml and 500 ml bottles. Its label indicates the indications for Dectomax and Dectomax-CA1, and each medication has a unique application number. The FDA stated that Dectomax already has full approval of a new animal drug application for the treatment and control of certain nematodes ...